Brokerages Set iRhythm Technologies, Inc. (NASDAQ:IRTC) PT at $116.10
iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price objective […]
HEICO Co. (NYSE:HEI) Receives Average Rating of “Moderate Buy” from Brokerages
HEICO Co. (NYSE:HEI – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ten brokerages that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among […]
First Advantage (NYSE:FA) Downgraded by Wolfe Research
Wolfe Research lowered shares of First Advantage (NYSE:FA – Free Report) from an outperform rating to a peer perform rating in a research report released on Thursday morning, MarketBeat Ratings reports. Several other equities analysts have also recently weighed in on the stock. Truist Financial cut their target price on shares of First Advantage from […]
Vertiv Holdings Co (NYSE:VRT) Receives Consensus Rating of “Buy” from Brokerages
Vertiv Holdings Co (NYSE:VRT – Get Free Report) has received an average rating of “Buy” from the nine ratings firms that are presently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the […]
Altria Group (NYSE:MO) PT Raised to $48.00 at Citigroup
Altria Group (NYSE:MO – Get Free Report) had its price target upped by equities research analysts at Citigroup from $44.50 to $48.00 in a research note issued on Tuesday, MarketBeat reports. The firm currently has a “neutral” rating on the stock. Citigroup’s target price would suggest a potential downside of 4.46% from the stock’s current […]
Analysts Set Pactiv Evergreen Inc. (NASDAQ:PTVE) Target Price at $14.57
Shares of Pactiv Evergreen Inc. (NASDAQ:PTVE – Get Free Report) have earned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month […]
Analysts Set Schrödinger, Inc. (NASDAQ:SDGR) PT at $33.44
Shares of Schrödinger, Inc. (NASDAQ:SDGR – Get Free Report) have received an average recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on […]
Analysts Set Veeva Systems Inc. (NYSE:VEEV) Price Target at $230.65
Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and sixteen have issued a buy recommendation on the company. […]
Anheuser-Busch InBev SA/NV (NYSE:BUD) Receives $73.25 Average PT from Analysts
Shares of Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a […]
BorgWarner Inc. (NYSE:BWA) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of BorgWarner Inc. (NYSE:BWA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the sixteen analysts that are covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month […]
Brokerages Set Cincinnati Financial Co. (NASDAQ:CINF) Target Price at $133.57
Cincinnati Financial Co. (NASDAQ:CINF – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 […]
Brokerages Set Jackson Financial Inc. (NYSE:JXN) Target Price at $80.00
Shares of Jackson Financial Inc. (NYSE:JXN – Get Free Report) have received a consensus rating of “Hold” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target […]
Brokerages Set Workiva Inc. (NYSE:WK) PT at $95.00
Workiva Inc. (NYSE:WK – Get Free Report) has earned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price target among […]
CompoSecure, Inc. (NASDAQ:CMPO) Given Consensus Recommendation of “Moderate Buy” by Analysts
CompoSecure, Inc. (NASDAQ:CMPO – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokers […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Given Average Recommendation of “Buy” by Brokerages
Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight brokerages that are presently covering the firm, Marketbeat reports. Seven equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The […]
Customers Bancorp, Inc. (NYSE:CUBI) Receives Average Rating of “Moderate Buy” from Analysts
Customers Bancorp, Inc. (NYSE:CUBI – Get Free Report) has earned an average rating of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. […]
EastGroup Properties, Inc. (NYSE:EGP) Given Consensus Recommendation of “Moderate Buy” by Brokerages
EastGroup Properties, Inc. (NYSE:EGP – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fifteen research firms that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month […]
Eaton Co. plc (NYSE:ETN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Eaton Co. plc (NYSE:ETN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seventeen research firms that are covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average […]
Equifax Inc. (NYSE:EFX) Given Consensus Recommendation of “Moderate Buy” by Analysts
Equifax Inc. (NYSE:EFX – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty ratings firms that are covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 12-month target price among […]
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives $60.00 Average PT from Analysts
Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among […]
Ingersoll Rand Inc. (NYSE:IR) Receives $101.17 Average Target Price from Brokerages
Ingersoll Rand Inc. (NYSE:IR – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $131.00 Average PT from Brokerages
Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have been given a consensus rating of “Buy” by the five ratings firms that are presently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have covered the stock […]
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned an average rating of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the […]
SM Energy (NYSE:SM) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of SM Energy (NYSE:SM – Get Free Report) have been given an average rating of “Moderate Buy” by the thirteen analysts that are covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month […]
last updated on 11 Oct 18:17